ABSTRACT The turnover of intestinal epithelial cells is a dynamic process that includes adequate cell proliferation and maturation in the presence of microbiota and migration and seeding of immune cells in early gut development in chickens. We studied the effect of yeastderived macromolecules (YDM) on performance, gut health, and immune system gene expression in the intestine of broiler chickens. One thousand eighty 1-d-old birds, with 60 birds per pen and 6 pens per treatment, were randomly assigned to 3 treatment diets; a diet containing monensin (control), control diet supplemented with bacitracin methylene disalycylate (BMD), and BMD diet supplemented with YDM. Feed intake, BW, mortality, ileum histomorphology, and gene expression of Toll-like receptors (TLR2b, TLR4, and TLR21), cytokines [interferon (IFN)-γ, IFN-β, , and transforming growth factor (TGF)-β4], and cluster of differentiation (CD)40 in the ileum, cecal tonsil, bursa of Fabricius, and spleen were assessed. No significant overall difference in performance in terms of feed intake, BW gain, and G:F was observed among treatments (P > 0.05). The YDM diet resulted in significantly higher villi height and villi height:crypt depth ratio compared with BMD and control diets (P < 0.05). A significantly lower mortality was observed in the YDM treatment compared with both control and BMD treatments. Compared with the control, gene expression analysis in YDM treatment showed no major change in response in the ileum, whereas higher CD40, in the cecal tonsil; TLR2b, TLR4, TLR21, and TGF-β4 in the bursa of Fabricius; and TLR4, IL12p35, in the spleen was observed (P < 0.05). In conclusion, supplementation of YDM supports pro-and anti-inflammatory cytokine production via T helper type 1 and 2 (Th1 and Th2) cell-associated pathways both locally and systemically with a stronger additive effect in the cecal tonsil in the presence of BMD in the diet of chickens.
INTRODUCTION
The vast majority of pathogens invade the body through or establish infections in the mucosal tissues. Intestinal mucosal immunostimulation has recently attracted much interest as a means of generating protective immunity against mucosal and systemic pathogens (Revolledo et al., 2006) . At hatch, the intestine of the chick is not fully developed, resulting in restricted optimal growth and immune competence, and increased susceptibility to pathogenic microbes (Uni et al., 1999) . Furthermore, the use of antibiotic growth promoters as feed additives results in an imbalance of normal microflora and a reduction in beneficial intestinal microflora, which play a pivotal role in the health status of chickens because of their involvement in nutritional, immunological, and physiological functions (Pedroso et al., 2006; Sen et al., 2012) . This microbiota shift can affect gut morphology and induce changes in intestinal immune response (Humphrey and Klasing, 2003) . Furthermore, it has been hypothesized that phagocytic cells can accumulate antibiotics, resulting in inhibition of the excretion of cytokines, thereby affecting acute phase responses and inflammation (Niewold, 2007) .
Yeast-derived products have been used as supplements for years for their nutritional content as well as their immunomodulatory properties to enhance performance and health of chickens (Savage and Zakrzewska, 1996; Westendorf and Wohlt, 2002) . Specifically, yeastderived macromolecules (YDM) have been studied as immunomodulators and nutritional supplements in promoting cell growth and controlling pathogenic microbes in chickens, turkeys, and pigs (Solis de los Santos, 2007; Fasina and Thanissery, 2011; Superchi et al., 2012) . A typical YDM composition includes a blend of yeast-derived nucleotides, inositol, protein, glutamic acid, vitamins, and minerals, among others (Jung and Batal, 2012) . It has been suggested that the beneficial action of yeast macromolecules as supplements is brought about by the nucleotide content of the product (Savage and Zakrzewska, 1996) . Nucleotides promote the growth and maturation of the developing gut cells in weanling rats with increased mucosal protein and DNA concentration in the jejunum by at least 50%, which was accompanied by an enhanced disaccharidase activity (Uauy et al., 1994) . In poultry experiments, inconsistent results have been reported about the effect of YDM on performance. Various studies reported no significant effect on growth performance parameters in broiler chickens (Morales-López et al., 2009; Thanissery et al., 2010; Fasina and Thanissery, 2011) . Dietary supplementation of YDM yeast extract has been shown to reduce Clostridium perfringens levels, and on d 1 postchallenge resulted in significantly increased alkaline phosphatase activity in the intestine of broiler chickens (Thanissery et al., 2010) .
Expanding information in immune system and nutrient interaction as well as rapid advances in developing defined immunomodulants containing Toll-like receptor (TLR) ligands indicate that a wide variety of safe and effective feed containing such molecules will be available in the future. Under TLR activation, heterophils can produce inflammatory mediators such as cytokines to help induce further immune responses (Farnell et al., 2003; Kogut et al., 2005) . In addition, resistance to pathogens, such as Salmonella spp., has closely been associated with an upregulation of TLR, mainly TLR4, and different chemokines and cytokines (Sadeyen et al., 2006; Chaussé et al., 2011) . Aberrant expression of TLR2, TLR4, and TLR21 has been associated with susceptibility to Salmonella enterica serovar Enteritidis infection in chickens (Gou et al., 2012) . There is limited information on the effect of YDM on local and systemic immune responses of broiler chickens mainly in regards to modulation of TLR, cytokines, and chemokines. Therefore, the current study was conducted to assess the effect of supplementing YDM in broiler diets, formulated to current industry nutrient standards, on performance, gut morphology, and the gastrointestinal tract as well as systemic immune modulation of TLR, chemokines, and cytokines.
MATERIALS AND METHODS
All experimental procedures were reviewed and approved by the University of Manitoba Animal Care Protocol Management and Review Committee, and chickens were handled according to the guidelines described by the Canadian Council on Animal Care (CCAC, 1993) .
Bird Trial
A total of 1,080 one-day-old Ross × Ross male broiler chickens were randomly assigned to 18 floor pens (a density of 10 birds/m 2 ) in a randomized complete block design. Three treatment diets were used with 6 pens per treatment. Dietary treatments were formulated to fulfill all nutrient requirements of birds in each phase according to NRC for starter (d 0 to d 14), grower (d 15 to 21), and finisher (d 22 to d 42; Table 1 ). Treatment diets were a diet containing 99 mg/kg of monensin (control), control supplemented with 110 mg/ kg of bacitracin methylene disalicylate (BMD), and a BMD diet supplemented with 0.02% YDM (NuPro, Alltech Inc., Nicholasville, KY). Birds were fed ad libitum. Feed intake (FI) and BW were measured on a weekly basis, where individual birds were weighed. At the end of the study (d 42), 5 birds per treatment were killed for sample collection. Birds were euthanized by cervical dislocation and immediately weighed; bursa of Fabricius and spleen weights were recorded for bursa/ BW and spleen/BW calculation, respectively. Samples of the ileum, cecal tonsil, bursa of Fabricius, and spleen were collected for gene expression studies.
Gut Histomorphology Analysis
Gut histomorphology was performed as previously described (Baurhoo et al., 2011) . Briefly, the terminal ileum and cecal tonsils were removed and immediately rinsed with saline solution. The tissue samples were placed in buffered formalin (10% neutral buffered formalin; Sigma-Aldrich, St. Louis, MO) for a period of 18 h. Samples were then rinsed 3 times with deionized water, placed in 70% ethanol, and set in paraffin blocks. In total, 5 samples from 5 birds, 1 bird from each of 5 pens per treatment, were sectioned per treatment and set on one glass slide, and the slides containing ileal and cecal tonsil sections were stained with Alcian blue (pH 2.5). The stained intestinal sections were used to measure the crypt depth, villus height, and width and for the determination of the number of goblet cells. Germinal centers were counted from the cecal tonsil sections. Villus height was measured from the tip of the villus to the top of the lamina propria, whereas villus width was measured at the basal and apical ends, excluding the crypt. Crypt depth was measured from the villus-crypt axis to the base of the specific crypt. Histological sections were examined with an Axioplan-2 optical microscope (Carl Zeiss Jena GmbH, Oberkochen, Germany) coupled with a refrigerated QImaging Retiga 4000R digital camera (QImaging, Surrey, BC, Canada) with a charge-coupled device detector. The images were analyzed using image software (MetaMorp Imaging System, Molecular Devices Ltd., Sunnyvale, CA).
Total RNA Extraction and Reverse Transcription
Total RNA was extracted from tissues samples from the ileum, cecal tonsil, bursa of Fabricus, and spleen sections using Trizol Reagent (Invitrogen Canada Inc., Burlington, Ontario, Canada) following the manufacturer's protocol. Methods of processing RNA and reverse transcription were carried out as described previously (Rodríguez-Lecompte et al., 2012) .
Quantitative Real-Time PCR
Quantitative real-time (qRT) PCR was performed using the Step One thermo cycler (Applied Biosystem, Mississauga, Ontario, Canada). A detailed description of the methodologies and the different parameters used has been described previously . Primer sequences for β-actin, TLR2b, TLR4, TLR21, , interferon (IFN)-γ, IFN-β, transforming growth factor (TGF)-β4, and cluster of differentiation (CD)40 were obtained from GenBank (Table 2) .
Calculations and Statistical Analysis
Performance parameters were analyzed as a randomized complete block design using the MIXED procedure of SAS (SAS Institute Inc., Cary, NC) with the fixed effects of block and treatment, and random effect of animal. Significance of the differences between means was assessed by an ANOVA according to the Scheffe's test. Relative expression levels of all genes were calculated relative to the housekeeping gene β-actin, and gene expression was presented as fold changes relative to the control diet. Gene expression fold changes, SE, and statistical significance were calculated using REST 2009 (Qiagen, Valencia, CA; Pfaffl, 2001) . All data were considered significantly different at P < 0.05. 
RESULTS
A summary of FI, BW gain, and G:F is given in Table 3. There was no significant difference in FI among treatments in the starter and grower phase, whereas a significantly higher FI was observed in BMD and YDM treatments compared with control in the finisher phase (P = 0.020). There was a significantly lower BW gain in BMD and YDM compared with control in the starter phase (P = 0.013). However, no significant difference was observed in the grower phase (P = 0.812), and a significantly higher BW was observed in BMD and YDM in the finisher phase compared with the control (P = 0.019). No significant difference in G:F was observed among treatments in all phases (P > 0.056). Cumulative FI, BW gain, and G:F was not significantly different among treatments (P > 0.055). Mortality was 40 and 48% lower in birds receiving the YDM diet compared with control and BMD diets, respectively. Gut morphology analysis of the ileum showed that YDM diet resulted in a significantly higher villi height and villi height:crypt depth ratio compared with control and BMD (P = 0.024 and 0.025, respectively). No significant difference in villi width and crypt depth was observed among treatments (P = 0.176 and 0.307, respectively). Significantly lower goblet cells/mm 2 were observed in both BMD and YDM diets compared with control (P = 0.001). Furthermore, no significant difference was observed in spleen and bursa of Fabricius weights relative to BW among treatments (P = 0.639 and 0.929, respectively; Table 4 ).
Gene expression analysis was performed on tissues collected from the ileum, cecal tonsil, bursa of Fabricius and spleen of 42-d-old chickens. Expression of TLR2b and TLR4 in both the ileum and cecal tonsil was not significantly different among treatments (P > 0.05). In the bursa of Fabricius, the BMD diet did not result in a significant up-or downregulation of TLR2b and TLR4 expression compared with the control (P > 0.866), whereas the YDM diet showed a significant upregulation of TLR2b compared with control and BMD diets (P = 0.003 and 0.001). Splenic TLR2b expression was not significantly different in both BMD and YDM diets compared with control (P = 0.278 and 0.956, respectively). However, a significant difference in TLR2b expression was observed between BMD and YDM diets (P = 0.031; Figure 1) . In both the bursa of Fabricius and spleen, BMD diet showed no significant difference in expression of TLR4 compared with the control (P > 0.05), whereas the YDM diet resulted in a significant upregulation in both tissues compared with the control (P = 0.019, and 0.004, respectively). There was a significantly higher expression of TLR4 in the YDM treatment compared with control and BMD treatments Figure  1B ). Expression of TLR21 in the ileum was not significantly different among treatments (P > 0.625). In the cecal tonsil, an upregulation of TLR21 was observed in the BMD and YDM diets compared with the control (P = 0.006 and 0.014, respectively). Both BMD and YDM diets resulted in a significant upregulation of TLR21 compared with the control in the bursa of Fabricius (P = 0.020 and 0.033, respectively). Compared with the control, the YDM diet resulted in a significant downregulation in TLR21 in the spleen (P = 0.046). There was no significant difference in expression of TLR21 between BMD and YDM treatments in all the tissues (P > 0.05) except in the spleen, where YDM resulted in significant downregulation of TLR21 compared with BMD (P < 0.001; Figure 1C ).
Cytokine gene expression analysis was also performed on the ileum, cecal tonsil, bursa of Fabricius, and spleen samples. Except in the cecal tonsil where a significant upregulation of IL-1β was observed in both BMD and YDM diets compared with the control (P = 0.006, and 0.002, respectively), there was no significant difference in the expression of IL-1β among treatments in all tissues (P > 0.05; Figure 2B ). Expression of IL-6 in the ileum showed a significant downregulation in the YDM diet compared with the control and BMD diets (P = 0.007, and 0.013, respectively). However, the YDM diet resulted in a significant upregulation in IL-6 compared with the control and BMD diets in the cecal tonsil (P < 0.001). A similar pattern as that of the ileum was observed in the bursa of Fabricius where expression of IL-6 was significantly downregulated in Means within a row sharing no common superscript differ significantly (P < 0.05). 1 Three experimental diets: control = diet containing Monensin; BMD = control supplemented with bacitracin methylene disalycylate, and YDM = BMD supplemented with yeast-derived macromolecules (NuPro, Alltech Inc., Nicholasville, KY).
2 Mortality was calculated from start to end of experiment, and chi-squared analysis was used for significant differences. the YDM diet compared with control and BMD diets (P = 0.05). In the spleen, there was no significant difference in the expression of IL-6 in BMD and YDM diets compared with the control (P > 0.05), whereas a significantly lower IL-6 expression was observed in the YDM diet compared with BMD (P = 0.01; Figure 2B) . No significant IL-8 expression difference was observed among treatments in all locations (P > 0.05; Figure 2C ). There was no significant difference in the expression of IFN-β in the ileum, bursa of Fabricius, and spleen among treatments (P > 0.05). However, in the cecal tonsil, significantly higher expression of IFN-β was observed in both the BMD and YDM diets compared with the control (P < 0.001). Furthermore, the YDM diet resulted in a significantly higher IFN-β expression compared with the BMD diet in the cecal tonsil (P < 0.001; Figure 2D ). Expression of both IL-12p35 and IFN-γ was not significantly different in the ileum, cecal tonsil, and bursa of Fabricius among treatments (P > 0.05). However, the YDM diet resulted in a significantly higher IL12p35 expression compared with the control and BMD diets in the spleen (P = 0.009, and 0.003, respectively; Figure 3A ). Splenic IFN-γ was not significantly different in the BMD treatment compared with the control (P = 0.352), whereas the YDM diet resulted in a significant upregulation of IFN-γ compared with the control (P = 0.043; Figure 3B ). Except for YDM treatment in the ileum where there was a significant IL-10 upregulation (P = 0.012), there was no significant difference in the expression of IL-10 among treatments in all the tissues (P > 0.05; Figure 4C ). Expression of IL-4 in the ileum was not significantly different among treatments (P > 0.05). In the cecal tonsil and spleen, IL-4 expression was significantly upregulated in the YDM treatment compared with control and BMD diets (P < 0.008 and 0.003, respectively), whereas no significant up or downregulation of IL-4 was observed in the BMD diet compared with the control in both tissues (P > 0.05). Expression of IL-4 in the bursa of Fabricius in the BMD diet was not significantly different compared with control (P > 0.05), whereas a downregulation of IL-4 was observed in the YDM treatment compared with the control and BMD diets (P = 021, and 0.001, respectively).
Expression of TGF-β4 and CD40 showed that in the ileum, although the BMD and YDM diets did not result in a significant difference compared with the control (P > 0.05), the BMD diet resulted in a significantly higher expression of TGF-β4 compared with the YDM diet (P < 0.011). However, in the cecal tonsil, the BMD and YDM diets resulted in a significantly higher TGF-β4 and CD40 expression compared with the control (P < 0.01), and the YDM diet resulted in a significantly higher expression of TGF-β4 and CD40 compared with the BMD diet (P = 0.005 and 0.031, respectively). In both the bursa of Fabricius and spleen, the YDM diet resulted in a significantly higher expression of TGF-β4 compared with both control and BMD diets (P < 0.007). In both the bursa of Fabricius and spleen, there was no significant CD40 expression difference among treatments (P > 0.05). Expression of IL-2 was not significantly different among treatments in the ileum, bursa of Fabricius, and spleen (P > 0.05). However, in the cecal tonsil, the BMD and YDM diets resulted in a significantly higher expression of IL-2 
DISCUSSION
At hatch, the intestine of the chick is not fully developed, resulting in restricted optimal growth and immune competence, and increased susceptibility to pathogenic microbes (Uni et al., 1999) . Among the various drawbacks in the use of antibiotic growth promoters as feed additives are the imbalance of normal microflora, and reduction in beneficial intestinal microflora that might affect intestinal turn-over and maturation of gut immuno-cells (Sen et al., 2012) . Yeast-derived macromolecules can have immunomodulatory, cell growth promoting, and pathogen microbe controlling capacity in chickens, turkeys, and pigs (Solis de los Santos, 2007; Jung and Batal, 2012) . Nucleotides in YDM have been shown to play a role in improving performance of birds (Bradley et al., 1994; Van Buren and Rudolph, 1997) . Overall performance of broiler chickens was not affected as a result of supplementation of YDM in the current study. The findings are in agreement with those of Owens and McCracken (2007) where supplementation of yeast extract at either 0.01 or 0.05% did not result in a significant difference in BW gain and G:F of broiler birds. Fasina and Thanissery (2011) showed that supplementing the diet of young hen chicks with yeast extract had no effect on growth, but improved G:F compared with the diet not supplemented with yeast extract; and the same extract resulted in improved BW gain and G:F in older hens. The findings of the current study are contrary to what Gao et al. (2008) showed where diets of broiler chicks supplemented with 0.25% yeast extract improved BW gain and G:F in 1 to 42 d of experiment. With regard to spleen and bursa of Fabricius weight relative to BW, no significant difference was observed among treatments in the current study, which is contrary to what Shivakumar et al. (2009) reported where commercial YDM, the same product used in the current study, resulted in significantly higher weights of both organs. Mortality was significantly lower in birds supplemented with yeast extract in the current study. However, Fasina and Thanissery (2011) showed no significant difference in mortality as a result of supplementation of yeast extract to the broiler diet. Histomorphological analysis in the ileum showed a higher villus height:crypt depth ratio in the YDM treatment, suggesting an increased epithelial cell turnover regulation as a result of feeding a YDM-supplemented diet (Awad et al., 2009 ). However, these histomorphological benefits were not translated into performance of birds because there was not difference between BMD and YDM treatments.
Toll-like receptors, also known as pathogen recognition receptors, are part of the innate immune system. These receptors recognize molecular patterns of pathogens called microbe-associated molecular patterns, causing a chain reaction and stimulating the immune system (Aderem and Ulevitch, 2000) . Chicken TLR2b, 4, and 21 are involved in recognition of peptidoglycan, lipopolysaccharides, and unmethylated CpG oligonucleotides, respectively (Hoshino et al., 1999; Fukui et al., 2001; Keestra et al., 2010) . The current study showed that neither BMD nor YDM resulted in a change in the expression of TLR2b and TLR4 in the ileum and cecal tonsil, suggesting that these receptors are not involved in regulation of innate immune responses in those locations as a result of supplementation of BMD or BMD plus YDM. Another possibility for this observation might be the fact that feeding BMD-supplemented diets for a long period might have reduced the bacterial population and thereby peptidoglycan and lipopolysaccharides present to elicit TLR2b and TLR4 responses, respectively. A stronger expression of TLR2b and TLR4 was observed in birds on YDM-supplemented diets in the current study in both the bursa of Fabricius and spleen. Chen et al. (2007) showed that increased TLR2b levels are associated with enhanced gastrointestinal epithelial barrier function against pathogens. Various studies have implicated TLR4 in recognition of glucuronoxylomannan (Shoham et al., 2001) and Saccharomyces cerevisiae and Candida albicans derivates (Tada et al., 2002) , and resistance to carrier states of Salmonella in chicks is associated with a higher level of expression of TLR4 (Sadeyen et al., 2006; Chaussé et al., 2011) . In the present study, an upregulated TLR21 expression was observed in chickens on BMDand YDM-supplemented diets in the cecal tonsil and bursa of Fabricius, whereas expression in the spleen was downregulated in the YDM treatment. Chicken TLR21 is a functional homolog to mammalian TLR9 and recognizes CpG oligodeoxynucleotides (CpG-ODN; He et al., 2012) . Various studies have reported the immune stimulatory characteristics of CpG-ODN in chicken (Patel et al., 2008; Brownlie et al., 2009; He et al., 2011b) . However, the TLR21 responses observed in the current study in YDM diet needs further investigation because of the possible differences in the nature of nucleotides present in YDM and synthetic CpG-ODN. Furthermore, addition of YDM-to BMD-supplemented diets might not result in appreciable changes in the expression of TLR21 because microbial debris, mainly bacterial nucleic acids, might be abundantly present after the killings of bacterial populations by BMD.
In the current study, higher IL-1β and IL-6 expression was observed in the cecal tonsil of chickens in the BMD and YDM diets compared with the control with a significant difference in IL-6 between them. Interleukin-1β has been shown, both in vitro and in vivo, to be a growth factor for B cell proliferation due to induction of IL-6, which is often under the control of IL-1β (Dinarello, 2009 ). Both IL-1β and IL-6 are pleiotrophic cytokines that regulate immune responses, and are commonly referred to as the proinflammatory cytokines produced as part of the induced innate response . The downregulation of IL-6 in YDM treatment in all the other tissues suggest that supplementation of YDM could have a potential in suppressing proinflammatory cytokines. No difference in IL-8 was observed among treatments in all tissues in the current study. Other studies have reported the relationship between high expression of IL-8 and resistance to pathogenic microorganisms such as Salmonella Enteritidis (Swaggerty et al., 2004; Sadeyen et al., 2006) . Interferon-β was upregulated in the cecal tonsil of birds receiving YDM compared with both control and BMD in the current study. Interferon-β has an immunomodulatory effect of activating natural killer (NK) cells, macrophages, and dendritic cells (DC), all of which are essential effector cells in the innate immune system (Takaoka and Yanai, 2006) . Therefore, the inclusion of YDM in broilers diets could modulate local innate immunity in broilers chickens.
Interleukin-12 promotes T helper type-1 (Th1) cell activity by inducing secretion of IFN-γ, and enhancing T and NK cell proliferation and cytotoxicity (Trinchieri, 2003; Rosenzweig and Holland, 2005) . Interferon-γ is involved in leukocyte attraction and directs growth, maturation, and differentiation of many cell types, in addition to enhancing NK cell activity and regulating B cell functions such as immunoglobulin production and class switching (Schroder et al., 2004 ). In the current study, higher expression of splenic IL-12p35, and IFN-γ was observed in birds receiving YDM diet compared with control, and higher IL-12p35 expression was observed in the YDM diet compared with the BMD diet in the spleen. Patel et al. (2008) showed that injection of chicks with oligodeoxynucleotides containing CpG-ODN motifs induced an upregulation of IFN-γ and IL-12, suggesting a Th-1-like immune response. In mice fed a diet supplemented with nucleotides, increased IFN-γ production by spleen cells was observed compared with a nonsupplemented diet (Nagafuchi et al., 1997) . Interleukin-10 has been described as a macrophage-inactivating regulatory cytokine that suppresses proinflammatory cytokine secretion and inhibits the expression of major histocompatibility class II and costimulatory molecules (O'Garra and Vieira, 2007) . In chickens the gene expression of IL-10 mRNA is superior in the duodenum rather than in the cecum of healthy chickens. In the current study, an upregulation of IL-10 was observed only in the ileum in birds receiving a YDM-supplemented diet compared with control, which can infer a local inhibition of the Th1 pathway.
Interleukin-4 induces characteristic Th-2 responses and is a major player in macrophage alternative activation, in which IL-4 antagonizes IFN-γ function and suppresses inflammatory immune response (Martinez et al., 2009) . He et al. (2011a) suggested that regulation of macrophage activity by Th1/2 cytokines is critically important to maintain a balanced immunity to provide an adequate Th1-mediated protective immunity while avoiding detrimental, excessive inflammation. In the present study, there was an upregulation of IL-4 in the BMD and YDM groups in the cecal tonsil and spleen compared with the control. However, spleen IL-4 gene expression was 24-fold more in birds receiving the YDM-supplemented diet compared with the BMD group, deducing some systemic activity of YDM on IL-4 expression and Th-2 responses. However, more work is warranted to characterize and understand much better the systemic role of YDM on IL-4 immunoregulation. Expression of TGF-β4 was upregulated in all the tissues except the ileum as a result of YDM supplementation to broiler diets. Transforming growth factor-β4 plays an important role in maintaining the balance between control and clearance of infectious organisms on the one hand and prevention of immune-mediated pathology on the other (Omer et al., 2000) . The proinflammatory role of TGF-β4 is accomplished by its ability to recruit monocytes, T cells, and neutrophils to the site of inflammation, whereas the anti-inflammatory role (normally at a high concentration) is played by the suppression IFN-γ production from NK cells among others (Espevik et al., 1987; Bellone et al., 1995) . The upregulation of TGF-β4 observed in this study is meriting more studies to correlate its anti-inflammatory effects and possible promotion of wound healing in birds receiving YDM-supplemented diets.
Cluster of differentiation 40 and its ligand interaction activate B cells and DC. In the former, CD40, in the presence of cytokines, can induce profound clonal expansion and differentiation to Ig secretion, while enhancing antigen presenting cell capacity of B cells; and in the later, CD40 activation of DC can, together with signals via TLR, manifest the licensing of DC to engender heightened proficiency in antigen presentation, cytokine and chemokine production, and extended survival (Quezada et al., 2004 ). In the current study, CD40 was upregulated only in the cecal tonsil with the supplementation of BMD and YDM. The cecal tonsil is characterized for the presence of areas of dense immune cell populations formed after antigen stimulation in peripheral lymphatic tissue, called germinal centers (Berek et al., 1991) , which have approximately 90% B-cells, 5 to 10% T-cells, and less than 1% follicular dendritic cells (Butch et al., 1993) . The latter are found on the surface of the germinal center and act to pull antigens in for further immune reaction as well as effecting B-cell proliferation and activity (Tew et al., 1997) . The effect of YDM could be as a result of the direct interaction with the cecal tonsil. In the current study, IL-2 expression was not affected as a result of YDM supplementation compared with BMD, whereas it was upregulated compared with the control in the cecal tonsil. Kogut et al. (2002) showed that a recombinant chicken IL-2 was capable of priming the phagocytic and bactericidal activities of heterophils from young chickens. However, the results observed are contrary to those of , where they demonstrated that IL-2 was able to prime expression of IL-8, whereas it did not affect the expression of IL-1β and IL-6.
In conclusion, supplementation of broiler chickens diet with YDM has shown the possible role of yeast extract as a nutritional supplement to enhance gut health in chickens' possible modulation in epithelial cell turnover as well as immunomodulation, even though this was not translated into an overall performance benefit. Supplementation of broiler diets with YDM resulted in both local and systemic immune responses where mainly TLR2 was involved locally, whereas only TLR4 was involved systemically with the production of both pro-and anti-inflammatory cytokines. Toll-like receptor-21 was not observed to be a major receptor involved as a result of YDM supplementation. Supplementation of YDM supports both a pro-and anti-inflammatory cytokine effect via Th1 and Th2 cell-associated pathways both locally and systemically with expressions of IL-2, systemically. Even though more research is required to elucidate the effect of YDM on immunomodulation under challenge conditions, the current study demonstrated that feeding YDM could have an immunostimulatory effect via local and systemic responses involving TLR, CD40, and balanced Th1/2 cytokines, with implications in enhancement of resistance to pathogenic microorganism invasion. Furthermore, because the cecal tonsil is an important organ in controlling the entry of bacteria and other pathogens into the ceca, the strong responses of the cytokines observed in the current study need further investigation in the role of YDM in limiting pathogen invasion.
